An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies.

Cornelia de Lange syndrome (CdLS) is a developmental genetic disorder. The characteristics of CdLS remain unexplored in the Chinese population. Now, a group of researchers from the National Center for Children’s Health, China, have examined the clinical presentations, mutational profiles, and hormonal therapy responses of Chinese children with CdLS. Mutations in three genes, correlation between mutations in a development-related gene and clinical presentations, and differential responses to hormone therapy were identified in Chinese patients.